Understand this story
On October 30, 2026, Fan Jie, President of Huawei's Pharmaceutical Business Unit, explicitly stated that "Huawei does not make drugs, nor does it do pipelines," and expressed the hope to become the technical foundation and ecosystem supporter of the AI pharmaceutical industry through computing power, storage, networking, toolchains, and data governance capabilities. He revealed that some cooperative projects have begun deploying computing clusters at the hundred-card scale; Huawei currently has a 1024-card super-node solution, and has worked with partners such as DP Technology, Wangshi Zhihui, and Molecular Heart to form an overall supporting solution.
AI-generated from public reports
Developments
1 confirmed developments
Fan Jie makes clear that Huawei will not make drugs or pipelines
Source:IT Home · AI
Reports and discussion timeline
Browse reports and discussion by time. Their evidence levels remain distinct.
Oct 30
IT Home · Artificial Intelligence
Fan Jie, President of Huawei's Pharmaceutical Business Unit, Clarifies "Huawei Does Not Make Drugs," Hopes to Become the Technical Foundation of the AI Pharmaceutical Industry
Fan Jie, President of Huawei's Pharmaceutical Business Unit, explicitly stated that "Huawei does not make drugs, nor does it develop pipelines," and hopes to become the technical foundation and ecosystem supporter of the AI pharmaceutical industry through computing power, storage, networking, toolchains, and data governance capabilities. He revealed that some cooperative projects have begun deploying hundred-card-scale computing clusters; Huawei currently has a 1024-card super-node solution, and has partnered with DP Technology, Stonewise, Molecular Heart, and others to form a complete supporting solution.